Case Report and Literature Review on Hematuria Following Pediatric Growth Hormone Testing

Jiayang Song published a case report and literature review on April 9, 2026. The document details a rare adverse drug reaction—hematuria—following arginine growth hormone stimulation testing in children. It includes a specific case presentation and aggregates findings from nine other case reports involving 15 patients.

Use Cases

• Analyze the incidence and characteristics of hematuria following arginine growth hormone testing based on the aggregated case reports.
• Study the typical onset and resolution timeline of this adverse reaction based on the described 1-3 day onset and 1-week resolution.
• Review hypothesized mechanisms for drug-induced hematuria based on the discussion of glomerular membrane permeability or immune response.
• Evaluate standard management strategies for this condition based on the described use of urine alkalinization and fluid supplementation.

Strengths

• Includes a detailed case presentation with patient age (11-year-and-3-month-old boy) and symptom timeline (7 hours post-test).
• Aggregates findings from nine case reports involving 15 patients, providing a broader context.
• The document is licensed under CC-BY-4.0, allowing for open sharing and reuse.

Limitations

• The dataset is a single PDF document (1.8 MB), not a structured data table.
• Row count and column-level documentation are absent; data extraction requires manual review.
• The data may reflect reporting bias inherent to published case reports.

Provenance

Source

figshare

Collection Method

Case report and literature review authored by Jiayang Song.

Freshness

Last updated 2026-04-09 05:15:34.